{"disease":{"id":"advanced-nonhematological-neoplasms","name":"advanced nonhematological neoplasms"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03370302","title":"A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics (PK) of TAK-228 as Single Agent in Adult East Asian Participants With Advanced Nonhematological Malignancies","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":28,"lead_sponsor_name":"Calithera Biosciences, Inc","has_results":true}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}